Stock Report From Crwe Wallstreet! Grhu.ob, Hpq, Jnj, Sbux, Agn

May 25, 2010 - PRLog -- GreenHouse Holdings, Inc. (OTCBB-GRHU.OB) The call for green jobs is being answered.

GreenHouse is answering the call for the creation of green jobs, green energy and
green business solutions by offering a wide range of products that support the
growing focus on an environmentally sustainable future. Its three primary business
segments—GreenHouse Builders, GreenHouse Energy and GreenHouse Community—address
broad markets from homeowners and the building industry to corporations,
governments, and Third World countries.

The way to the future, and to the creation of the 8 plus million jobs America needs,
is through going green, and it’s also environmentally smart.




HP  and Alcatel-Lucent recently announced they will provide new communication solutions, allowing clients to easily adopt and deploy Unified Communications and Collaboration (UC&C) to drive greater organizational value.

Building on the companies’ global alliance, this agreement enables HP and Alcatel-Lucent to deliver and market end-to-end UC&C solutions to clients. These solutions use the convergence of telecommunications and IT to transform the way customers use UC&C services.



Johnson & Johnson  will host a review of its Medical Devices & Diagnostics business for the investment community, beginning at 8:30 a.m. (Eastern Time) on Thursday, June 3rd.

Alex Gorsky, Worldwide Chairman, Medical Devices & Diagnostics (MD&D) for Johnson & Johnson, will host the meeting at the Hyatt Regency Hotel in New Brunswick, N.J. He will be joined by senior leaders of MD&D's seven franchises: Cordis, DePuy, Diabetes Care, Ethicon, Ethicon Endo-Surgery, Ortho Clinical Diagnostics and Vision Care.



Starbucks Coffee Company  announced the appointment of Jeff Hansberry to the role of president, Starbucks Global Consumer Products Group (CPG) and Foodservice. He will lead Starbucks efforts to accelerate growth in the company’s consumer products business with the introduction of new brands and products to more markets around the world. Hansberry will report to chairman, president and ceo Howard Schultz.



Allergan, Inc.  announced that the United States Food and Drug Administration (FDA) has approved ZYMAXID™ (gatifloxacin ophthalmic solution) 0.5%, a topical fluoroquinolone anti-infective indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms; Haemophilus influenzae, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus mitis group*, Streptococcus oralis*, Streptococcus pneumonia. ZYMAXID™ is now the highest concentration gatifloxacin ophthalmic solution on the market in the United States.





******************************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEWallStreet publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEWallStreet.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has previously been compensated five thousand dollars for 30 days of advertisement services for Greenhouse Holdings (OTC BB: GRHU.OB) which has expired. Crown Equity Holdings, Inc. (CRWE.OB) has been compensated an additional five thousand dollars for an additional 30 days of advertisement services for Greenhouse Holdings (OTC BB: GRHU.OB)Bookmark